These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6234759)

  • 1. Activator proteins for the catabolism of glycosphingolipids.
    Li YT; Li SC
    Adv Exp Med Biol; 1984; 174():213-26. PubMed ID: 6234759
    [No Abstract]   [Full Text] [Related]  

  • 2. Sphingolipid hydrolases and activator proteins.
    Bierfreund U; Kolter T; Sandhoff K
    Methods Enzymol; 2000; 311():255-76. PubMed ID: 10563332
    [No Abstract]   [Full Text] [Related]  

  • 3. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 4. Activator proteins for lysosomal glycolipid hydrolysis.
    Conzelmann E; Sandhoff K
    Methods Enzymol; 1987; 138():792-815. PubMed ID: 2885714
    [No Abstract]   [Full Text] [Related]  

  • 5. Synopsis: gangliosidoses.
    Schwab ME; Vassella F
    Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein activator for the enzymic hydrolysis of GM2 ganglioside.
    Li SC; Hirabayashi Y; Li YT
    J Biol Chem; 1981 Jun; 256(12):6234-40. PubMed ID: 7240201
    [No Abstract]   [Full Text] [Related]  

  • 7. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
    Wynn CH
    Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolipid-binding proteins.
    Sasaki T
    Chem Phys Lipids; 1985 Aug; 38(1-2):63-77. PubMed ID: 4064224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and specificity of human GM2 activator protein.
    Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
    J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
    J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
    Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
    J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
    Burg J; Banerjee A; Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
    Inui K; Wenger DA
    Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
    Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Function and relevance of activator proteins for glycolipid degradation].
    Sandhoff K
    Seikagaku; 1985 Feb; 57(2):87-102. PubMed ID: 3925052
    [No Abstract]   [Full Text] [Related]  

  • 17. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activator proteins and topology of lysosomal sphingolipid catabolism.
    Fürst W; Sandhoff K
    Biochim Biophys Acta; 1992 Jun; 1126(1):1-16. PubMed ID: 1606169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
    J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.